RESVORM Trademark

Trademark Overview

On Tuesday, August 23, 2016, a trademark application was filed for RESVORM with the United States Patent and Trademark Office. The USPTO has given the RESVORM trademark a serial number of 79196731. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 17, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The RESVORM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
resvorm

General Information

Serial Number79196731
Word MarkRESVORM
Filing DateTuesday, August 23, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 17, 2023
Registration Number5193598
Registration DateTuesday, May 2, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 6, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, December 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Thursday, December 8, 2016NON-FINAL ACTION WRITTEN
Friday, December 9, 2016REFUSAL PROCESSED BY MPU
Friday, December 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 13, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, December 20, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 22, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 22, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 22, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017REGISTERED-PRINCIPAL REGISTER
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Wednesday, January 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, May 2, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 17, 2023CANCELLED SECTION 71
Monday, August 5, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, August 5, 2024INVALIDATION PROCESSED
Saturday, August 5, 2017FINAL DISPOSITION PROCESSED
Saturday, August 5, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 18, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, August 24, 2024TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

resvorm system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary